Javier R. Revollo

3.4k total citations · 2 hit papers
45 papers, 2.7k citations indexed

About

Javier R. Revollo is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Javier R. Revollo has authored 45 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 10 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Javier R. Revollo's work include CRISPR and Genetic Engineering (17 papers), DNA Repair Mechanisms (8 papers) and Carcinogens and Genotoxicity Assessment (6 papers). Javier R. Revollo is often cited by papers focused on CRISPR and Genetic Engineering (17 papers), DNA Repair Mechanisms (8 papers) and Carcinogens and Genotoxicity Assessment (6 papers). Javier R. Revollo collaborates with scholars based in United States, Mexico and Saudi Arabia. Javier R. Revollo's co-authors include Shin‐ichiro Imai, Andrew A. Grimm, John A. Cidlowski, Tao Wang, Cynthia Wolberger, Xiaoling Li, Biplab Dasgupta, Kathryn F. Mills, Akiko Satoh and Yo Sasaki and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Javier R. Revollo

42 papers receiving 2.7k citations

Hit Papers

The NAD Biosynthesis Pathway Mediated by Nicotinamide Pho... 2004 2026 2011 2018 2004 2007 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javier R. Revollo United States 14 1.1k 899 862 823 592 45 2.7k
In Hye Lee South Korea 19 1.3k 1.1× 1.8k 2.0× 2.0k 2.4× 887 1.1× 304 0.5× 38 4.1k
Hyeog Kang United States 17 547 0.5× 357 0.4× 1.1k 1.3× 592 0.7× 178 0.3× 27 2.0k
Daniel X. Tishkoff United States 15 730 0.7× 471 0.5× 2.2k 2.6× 419 0.5× 302 0.5× 16 3.2k
Chang Hwa Jung United States 8 213 0.2× 2.9k 3.3× 2.2k 2.5× 444 0.5× 152 0.3× 9 4.2k
Francesco Vetrini United States 13 197 0.2× 3.1k 3.5× 2.5k 2.9× 977 1.2× 196 0.3× 31 5.3k
Mhairi C. Towler United Kingdom 17 167 0.2× 401 0.4× 2.0k 2.3× 574 0.7× 158 0.3× 19 2.8k
Vinicia Assunta Polito Italy 10 115 0.1× 1.9k 2.1× 1.4k 1.6× 812 1.0× 219 0.4× 11 3.3k
Chiara Di Malta Italy 15 204 0.2× 3.3k 3.6× 2.5k 2.9× 1.3k 1.6× 147 0.2× 19 5.6k
Hai‐Bin Ruan United States 27 189 0.2× 612 0.7× 1.9k 2.2× 1000 1.2× 244 0.4× 51 3.3k

Countries citing papers authored by Javier R. Revollo

Since Specialization
Citations

This map shows the geographic impact of Javier R. Revollo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javier R. Revollo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javier R. Revollo more than expected).

Fields of papers citing papers by Javier R. Revollo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javier R. Revollo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javier R. Revollo. The network helps show where Javier R. Revollo may publish in the future.

Co-authorship network of co-authors of Javier R. Revollo

This figure shows the co-authorship network connecting the top 25 collaborators of Javier R. Revollo. A scholar is included among the top collaborators of Javier R. Revollo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javier R. Revollo. Javier R. Revollo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Xiaoqing, et al.. (2025). Mutation accumulation following extended exposure of human HepaRG cells to a genotoxic carcinogen. PubMed. 43(4). 333–355. 1 indexed citations
2.
Seo, Ji‐Eun, Javier R. Revollo, Page B. McKinzie, et al.. (2024). Evaluating the mutagenicity of N-nitrosodimethylamine in 2D and 3D HepaRG cell cultures using error-corrected next generation sequencing. Archives of Toxicology. 98(6). 1919–1935. 15 indexed citations
3.
Sung, Kidon, Mohamed S. Nawaz, Javier R. Revollo, et al.. (2024). Complete genome sequence of cephalosporin and tetracycline-resistant Citrobacter freundii CF51 isolate from a patient with urinary tract infection. Microbiology Resource Announcements. 13(10). e0032524–e0032524.
4.
Revollo, Javier R., et al.. (2023). Draft Genome Sequences of 14 Fluoroquinolone-Resistant Escherichia coli Isolates from Imported Shrimp. Microbiology Resource Announcements. 12(4). e0111622–e0111622. 1 indexed citations
5.
Dobrovolsky, Vasily N., Tomonari Matsuda, Page B. McKinzie, J. Jaime Miranda, & Javier R. Revollo. (2023). Whole-genome high-fidelity sequencing: A novel approach to detecting and characterization of mutagenicity in vivo. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 891. 503691–503691. 1 indexed citations
7.
Revollo, Javier R., Mason G. Pearce, Roberta A. Mittelstaedt, et al.. (2020). CD59‐deficient bone marrow erythroid cells from rats treated with procarbazine and propyl‐nitrosourea have mutations in thePig‐agene. Environmental and Molecular Mutagenesis. 61(8). 797–806. 3 indexed citations
8.
McGrath, Erica L., Linyi Zhang, Je‐Nie Phue, et al.. (2019). Targeting specificity of APOBEC-based cytosine base editor in human iPSCs determined by whole genome sequencing. Nature Communications. 10(1). 5353–5353. 50 indexed citations
9.
Mittelstaedt, Roberta A., Vasily N. Dobrovolsky, Javier R. Revollo, et al.. (2018). Evaluation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) mutagenicity using in vitro and in vivo Pig-a assays. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 837. 65–72. 5 indexed citations
10.
Revollo, Javier R., et al.. (2018). Genome-wide mutation detection by interclonal genetic variation. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 829-830. 61–69. 11 indexed citations
11.
Dobrovolsky, Vasily N., Javier R. Revollo, Dayton M. Petibone, & Robert H. Heflich. (2017). In Vivo Rat T-Lymphocyte Pig-a Assay: Detection and Expansion of Cells Deficient in the GPI-Anchored CD48 Surface Marker for Analysis of Mutation in the Endogenous Pig-a Gene. Methods in molecular biology. 1641. 143–160. 8 indexed citations
12.
Revollo, Javier R., Yiying Wang, Page B. McKinzie, et al.. (2017). Spectrum of benzo[ a ]pyrene-induced mutations in the Pig-a gene of L5178Y Tk +/− cells identified with next generation sequencing. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 824. 1–8. 13 indexed citations
13.
Revollo, Javier R., Dayton M. Petibone, Page B. McKinzie, et al.. (2015). Whole genome and normalized mRNA sequencing reveal genetic status of TK6, WTK1, and NH32 human B-lymphoblastoid cell lines. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 795. 60–69. 8 indexed citations
14.
Revollo, Javier R., Mason G. Pearce, Dayton M. Petibone, Roberta A. Mittelstaedt, & Vasily N. Dobrovolsky. (2015). Confirmation of Pig-a mutation in flow cytometry-identified CD48-deficient T-lymphocytes from F344 rats. Mutagenesis. 30(3). 315–324. 28 indexed citations
15.
Dobrovolsky, Vasily N., et al.. (2015). CD48‐deficient T‐lymphocytes from DMBA‐treated rats have de novo mutations in the endogenous Pig‐a gene. Environmental and Molecular Mutagenesis. 56(8). 674–683. 21 indexed citations
16.
Revollo, Javier R. & Xiaoling Li. (2013). The ways and means that fine tune Sirt1 activity. Trends in Biochemical Sciences. 38(3). 160–167. 131 indexed citations
17.
Revollo, Javier R., Antje Körner, Kathryn F. Mills, et al.. (2007). Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme. Cell Metabolism. 6(5). 363–375. 753 indexed citations breakdown →
18.
Revollo, Javier R., Andrew A. Grimm, & Shin‐ichiro Imai. (2007). The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals. Current Opinion in Gastroenterology. 23(2). 164–170. 252 indexed citations
19.
Wang, Tao, Xiangbin Zhang, Poonam Bheda, et al.. (2006). Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme. Nature Structural & Molecular Biology. 13(7). 661–662. 234 indexed citations
20.
Revollo, Javier R., Andrew A. Grimm, & Shin‐ichiro Imai. (2004). The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells. Journal of Biological Chemistry. 279(49). 50754–50763. 818 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026